Rense.com




Uncommon Bacteria Found
In 7 NY Babies, 4 Die

From Patricia Doyle, PhD
dr_p_doyle@hotmail.com
7-31-4
 
Hello, Jeff - This is a very perplexing situation at the Medical Center. It does sound as though Dr. Michael Gewitz is trying to quell some culpability on the part of the medical center. He is attempting to claim the infant deaths probably would have occurred anyway, even if the babies were not infected.
 
In the summer of 1983, the same neonatal intensive care unit and the maternity floor had a problem with infection control and had reoccurring Staph outbreaks throughout the summer. I had firsthand knowledge of a patient and her newborn daughter who were infected with Staph that summer. The hospitals answer to the second Staph outbreak was to send the infected baby home as soon as possible and the severely ill Mom was transferred to the Oncology floor. (She did not have cancer however the hospital transferred her due to the Staph infection. The mother had gone into respiratory arrest during the C-Section after given an overdose of anesthesia.)
 
Hopefully, the hospital will find out HOW the bacteria had infected the babies.
 
Patricia Doyle
 
 
http://www.wnbc.com/health/3596719/detail.html
 
 
 
Uncommon Bacteria Found In 7 Babies, 4 Die
 
UPDATED: 2:12 pm EDT July 30, 2004
 
VALHALLA, N.Y. -- Seven premature babies at a Westchester hospital tested positive for bacteria rarely found in infants, and four of them have died.
 
The extremely premature babies all suffered multiple medical problems, and two who died were not expected to survive regardless of the bacteria, Westchester Medical Center officials told The Journal News. Some weighed less than a pound.
 
Dr. Michael Gewitz, director of pediatrics, told the newspaper it was nearly impossible to say whether the bacteria, acinetobacter, contributed to the babies' deaths. He said some just had it on their skin, not in their blood.
 
The bacteria, which is not uncommon in ailing adult patients, was identified by routine blood cultures about two weeks ago at Westchester Medical Center in a baby who had been transferred from another hospital.
 
Other babies were checked for the bacteria, and the six who tested positive were isolated, Gewitz said. The surviving babies are being treated with antibiotics.
 
Twenty-nine other babies tested negative for the bacteria, which spreads by contact. The hospital's neonatal intensive-care unit is a regional center that typically treats the sickest premature infants in the Hudson Valley region.
 
Acinetobacter infections might cause a fever or other symptoms in adults, but the babies showed no signs of the bacteria's presence, Gewitz said in the newspaper's Friday report. Testing positive for acinetobacter does not mean there is an infection.
 
"In these babies, it's hard to make that call because they have so many other serious problems associated with their basic illness of being extremely premature," he said.
 
© 2004 by The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
 
 
I sincerely apologize for adding the wrong file from my notes. I was too hasty in clicking on my file which is in alphabetical order of bacteria files in my computer and hit the wrong bacteria.
 
Please forgive me for the error and I sincerely thank Jeff Rense for posting the correct information.
 
Sincerely,
Patricia Doyle
 
Correction: Acinetobacter
 
ACINETOBACTER
Acinetobacter species are oxidase-negative, non-motile bacteria which appear as Gram-negative coccobacilli in pairs under the microscope. Identifying the different species of this genus can be done through the use of FLN (Flourescence-Lactose-Denitrification medium) acid results which determines the amount of acid produced from metabolizing glucose. Also, most members of Acinetobacter show good growth on MacConkey agar with the exception of some A. lwoffii strains. Although many species of Acinetobacter can cause infection, A. baumannii is the most frequently encountered species in the clinical laboratory. Like Pseudomonas, A. baumannii can be linked to many hospital acquired infections including skin and wound infections, pneumonia, and meningitis. A. lwoffi, in particular, is responsible for most cases of meningitis caused by Acinetobacter. Because most species are resistant to penicillin and chloramphenicol, a combination of aminoglycoside and ticarcillin is usually recommended for treatment.
 
LABORATORY INDICATIONS:
Oxidase -
Non-motile
Penicillin resistance (most strains)
 
Also for more information:
 
http://arch.rivm.nl/enemti/The%20genus%20Acinetobacter.htm
 
The Acinetobacter Working Group
 
 
Introduction
 
Bacteria of the genus Acinetobacter are widespread in nature, and can be recovered from water, soil and living organisms. They are non-motile, coccobacillary, strictly aerobic and Gram-negative; they can use a variety of carbon sources for growth, and can be cultured on relatively simple media, including trypticase soya agar or nutrient agar. Extensive reviews of the genus have been written by Juni (15) and by Bergogne-Bérézin & Towner (1). Strains of A. baumannii, and the unnamed groups 3 and 13 TU are recovered predominantly from clinical specimens, with A. baumannii being notorious for its capacity to colonise and infect severely ill, hospitalised patients. Strains of this genomic species can persist in hospitals and give rise to outbreaks; they are usually highly resistant to antibiotics, which makes them difficult to eradicate.
 
Two recently described species, A. ursingii ('phenon 1') and A. schindlerii ('phenon 2') (17, 18) are also associated with patients; thus A. ursingii was cultured from the blood of severely ill hospitalised patients, and A. schindlerii from non-sterile body sites of outpatients. Most other (genomic) species of Acinetobacter have been found in different environments, e.g. strains of A. calcoaceticus are isolated predominantly from soil and A. johnsonii from activated sludge and frozen food, although representatives of these and other species have also been recovered occasionally from human specimens. Strains of A. venetianus, including the emulsan-producing strain RAG-1, have been found in seawater and oil-degrading consortia (7, 22). Overall, the natural habitats of most Acinetobacter (genomic) species have not been well-studied.
 
Within the context of ENEMTI, the Acinetobacter Working Group will seek to develop two different protocols that can be used for the development of an interactive database for the exchange of microbial typing database:-
 
(i) a high-resolution typing method suitable for use in reference laboratories: AFLP protocol
 
(ii) a simpler rapid typing method for use in routine hospital laboratories: RAPD method
 
The ENEMTI initiative aims to harmonise typing methods so that the fingerprints generated can be used to set up electronic databanks by which the geographic spread of particular strains can be depicted and monitored.
 
ENEMTI participants have also collaborated with members of the EU ARPAC Concerted Action ('Antibiotic Resistance Prevention and Control') to develop an Acinetobacter database based on pulsed-field gel electrophoresis (PFGE) fingerprint profiles. Click here [http://bioinformatics.phls.org.uk/acine/acinepfge.htm] to enter the Acinetobacter PFGE database.
 
More information on the genus Acinetobacter, a heterogeneous group of organisms
 
Taxonomy
 
Currently, the genus Acinetobacter comprises at least 23 genomic species (DNA-DNA hybridisation groups; DNA groups), 10 of which have been given species names; other DNA groups are designated by numbers (for Table 1, see the original Word document). The numbers 13-15 have been given to sets of strains in two independent studies (6, 20); DNA group 13 of Bouvet & Jeanjean (BJ) has been found to correspond to group 14 of Tjernberg & Ursing (TU), whereas no correlation was found for the two other groups. Strains of A. calcoaceticus, A. baumannii, and the unnamed groups 3 and 13TU are genetically closely related and difficult to separate phenotypically, and are therefore sometimes unified in the so-called A. calcoaceticus A. baumannii (Acb) complex (10). Apart from the known genomic species, additional strains have been found, some of which are closely related to the Acb complex (12), while the taxonomic status of others has not yet been resolved.
 
Genus identification
 
Bacteria can be identified to the genus Acinetobacter by the phenotypic criteria listed in Table 2 (see the original Word document). A simple test for identification to the genus Acinetobacter is based on the finding that DNA of organisms belonging to the genus can be used to transform an auxotrophic Acinetobacter strain (BD413 trpE27) to prototrophy (14).
 
(Genomic) species identification
 
DNA-DNA hybridisation is the gold standard for identification of Acinetobacter strains, but this method is not applicable in most laboratories. A phenotypic identification scheme, including enzymatic and nutritional tests and growth at different temperatures, was devised by Bouvet & Grimont (4, 5). Several studies have shown that some genomic species are difficult to identify by phenotypic tests (10, 16). Similarly, commercial phenotypic identification systems, such as API 20NE and Biolog, show only moderate performance (2, 3). In particular, A. baumannii, DNA groups 3 and 13TU are difficult to differentiate by these systems.
 
Several genotypic methods have been proposed for identifying acinetobacters to the genomic species level, including ribotyping (11), tDNA fingerprinting (9), amplified ribosomal DNA restriction analysis (ARDRA) (8, 21), and AFLP (13). An overview of ARDRA patterns for species identification can be found at http://allserv.rug.ac.be/~mvaneech/LBR.html.
 
Despite the progress made in subdividing the genus Acinetobacter and the efforts to develop easy identification methods, identification to the genomic species level can still be problematic. This may be overcome by using a combination of methods, which results in a so-called 'consensus identification' (17).
 
Typing of Acinetobacter strains
 
Virtually all currently available typing methods have been used for discrimination of acinetobacters below the species level. Phenotypic methods, including biotyping, cell envelope protein electrophoresis, and quantitative antibiogram typing were applied successfully in the 1980s and 1990s. More recently, genotypic methods including plasmid typing (now rarely used), ribotyping, pulsed-field gel electrophoresis (PFGE), PCR fingerprinting and AFLP analysis have been used in numerous studies. In general, a combination of typing methods is recommended for unambiguous strain identification in local situations.
 
References
 
 
 
Bergogne-Bérézin E & Towner KJ (1996). Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9, 148-165.
Bernards AT, Dijkshoorn L, van der Toorn J, Bochner BR & van Boven CPA (1995). Phenotypic characterization of Acinetobacter strains of 13 DNA-DNA hybridization groups by means of the Biolog system. J Med Microbiol 42, 113-119.
Bernards AT, van der Toorn J, van Boven CPA. & Dijkshoorn L (1996). Evaluation of the ability of the API 20NE system to identify Acinetobacter genomic species. Eur J Clin Microbiol Infect Dis 15, 303-308.
Bouvet PJM & Grimont PAD (1986). Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov., and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int J Syst Bacteriol 36, 228-240.
Bouvet PJM & Grimont PAD (1987). Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur/Microbiol 138, 569-578.
Bouvet PJM & Jeanjean S (1989). Delineation of new proteolytic genomic species in the genus Acinetobacter. Res Microbiol 140, 291-299.
DiCello F, Pepi M, Baldi F & Fani R (1997). Molecular characterization of an n-alkane-degrading bacterial community and identification of a new species, Acinetobacter venetianus. Res Microbiol 148, 237-249.
Dijkshoorn L, van Harsselaar B, Tjernberg I, Bouvet PJM & Vaneechoutte M (1998). Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species. Syst Appl Microbiol 21, 33-39.
Ehrenstein B, Bernards AT, Dijkshoorn L, Gerner-Smidt P, Towner KJ, Bouvet PJ, Daschner FD & Grundmann H (1996). Acinetobacter species identification by using tRNA spacer fingerprinting.J Clin Microbiol 34, 2414-2420.
Gerner-Smidt P, Tjernberg I & Ursing J (1991). Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol 29, 277-282.
Gerner-Smidt P (1992). Ribotyping of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. J Clin Microbiol 30, 2680-2685
Gerner-Smidt P & Tjernberg I (1993). Acinetobacter in Denmark: II. Molecular studies of the Acinetobacter calcoaceticus- Acinetobacter baumannii complex. APMIS 101, 826-832.
Janssen P, Maquelin K, Coopman R, Tjernberg I, Bouvet P, Kersters K & Dijkshoorn L (1997). Discrimination of Acinetobacter genomic species by AFLP fingerprinting. Int J Syst Bacteriol 47, 1179-1187.
Juni E (1972). Interspecies transformation of Acinetobacter: Genetic evidence for a ubiquitous genus. J Bacteriol 112, 917-931.
Juni E (1984). Genus III Acinetobacter Brisou and Prévot 1954, 727 AL. In: Bergey,s Manual of Systematic Bacteriology vol. 1, Krieg, N.R. (ed). Williams and Wilkins, Baltimore, pp 303-307.
Kämpfer P, Tjernberg I & Ursing J (1993). Numerical classification and identification of Acinetobacter genomic species. J Appl Bacteriol 75, 259-268.
Nemec A, Dijkshoorn L & Je°ek P (2000). Recognition of two novel phenons of the genus Acinetobacter among glucose non-acidifying isolates from human specimens. J Clin Microbiol 38, 3937-3941.
Nemec A, De Baere T, Tjernberg I, Vaneechoutte M, van der Reijden TJK & Dijkshoorn L (2001). Acinetobacter ursingii sp.nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol, in press.
Nishimura Y, Ino T & Iizuka H (1988). Acinetobacter radioresistens sp. nov. isolated from cotton and soil. Int J Syst Bacteriol 38, 209-211.
Tjernberg I & Ursing J (1989). Clinical strains of Acinetobacter classified by DNA-DNA hybridization. APMIS 97, 595-605.
Vaneechoutte M, Dijkshoorn L, Tjernberg I, Elaichouni A, de Vos P, Claeys G & Verschraegen G (1995). Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol 33, 11-15.
Vaneechoutte M, Tjernberg I, Baldi F, Pepi M, Fani R, Sullivan ER, van der Toorn J & Dijkshoorn L (1999). Oil-degrading Acinetobacter strain RAG-1 and strains described as 'Acinetobacter venetianus' sp. nov. belong to the same genomic species. Res Microbiol 150, 69-73.

 
 
 
Patricia A. Doyle, PhD
Please visit my "Emerging Diseases" message board at: http://www.clickitnews.com/ubbthreads/postlist.php?Cat=&Board=emergingdiseases
Zhan le Devlesa tai sastimasa
Go with God and in Good Health




Disclaimer






MainPage
http://www.rense.com


This Site Served by TheHostPros